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Abstract
Computed tomography (CT) is a non-invasive imaging modality used to monitor human lung cancers. Typically, tumor
volumes are calculated using manual or semi-automated methods that require substantial user input, and an exponential
growth model is used to predict tumor growth. However, these measurement methodologies are time-consuming and can
lack consistency. In addition, the availability of datasets with sequential images of the same tumor that are needed to
characterize in vivo growth patterns for human lung cancers is limited due to treatment interventions and radiation
exposure associated with multiple scans. In this paper, we performed micro-CT imaging of mouse lung cancers induced by
overexpression of ribonucleotide reductase, a key enzyme in nucleotide biosynthesis, and developed an advanced semi-
automated algorithm for efficient and accurate tumor volume measurement. Tumor volumes determined by the algorithm
were first validated by comparison with results from manual methods for volume determination as well as direct physical
measurements. A longitudinal study was then performed to investigate in vivo murine lung tumor growth patterns.
Individual mice were imaged at least three times, with at least three weeks between scans. The tumors analyzed exhibited
an exponential growth pattern, with an average doubling time of 57.08 days. The accuracy of the algorithm in the
longitudinal study was also confirmed by comparing its output with manual measurements. These results suggest an
exponential growth model for lung neoplasms and establish a new advanced semi-automated algorithm to measure lung
tumor volume in mice that can aid efforts to improve lung cancer diagnosis and the evaluation of therapeutic responses.
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Introduction
Lung cancer is the leading cause of cancer death among both
men and women worldwide. The five-year survival rate for lung
cancer is only 16%, as compared to 89% and 100% for breast and
prostate cancers, respectively. If lung cancers are detected and
treated in their earliest stages, the survival rate can be improved to
92% [1]. Not only is the detection of lung tumors critical, but
measuring disease progression and treatment response also are
important for improving patient care. Such clinical data can be
collected using non-invasive imaging techniques, such as X-ray
computed tomography (CT). CT images are generated based on
X-ray attenuation by tissues, with the degree of attenuation
proportional to the tissue density. CT instruments generate a series
of 2D X-ray images, which can be reconstructed to produce a 3D
image. Based on these images, clinicians can identify and measure
potential lung neoplasms.
Tumor size and growth rate are key criteria for cancer staging
and can be used to evaluate the effectiveness of therapies.
Measurement of these parameters must be efficient and accurate
in order for CT scans to be useful for clinical purposes. Manual
measurements by clinicians have been used widely to assess tumor
volumes in human patients. However, these methods are often
time-consuming and labor intensive. Manual measurements are
also subject to high inter- and intra-observer variability. Several
studies have suggested that manual measurements of tumor size by
radiologists are inconsistent [2,3,4] and should not be relied upon
to provide ground truth. In response to these issues, semi-
automated measurement methods have been developed to
improve tumor measurement efficiency and reduce inconsistency
among radiologists. However, the existing semi-automated meth-
ods typically require extensive manual intervention. For example,
an algorithm described by Haines et al. [5] required the selection
of the total chest space volume, excluding the heart, through a
combination of manual segmentation and semi-automated con-
touring. In this case, tumor and vasculature tissue were not
separated, and the combined volume of both was used as a relative
measure of tumor burden. The measurement method developed
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by Fushiki et al. [6] also required manual segmentation of the
chest volume. Cody et al. [7] used a method that did not require
manual segmentation of the chest volume, but often required
manual editing of the automatically determined contours. Namati
et al. [8] described a semi-automated method that required only a
single stroke across the cross-section of the tumor to initialize the
algorithm, but also required manual editing of the automated
segmentation. A recent study by Rodt et al. quantified tumor
growth on longitudinal micro-CT scans. However, their measure-
ment method required 20-40 manually specified seed points [9].
As a result, there has been an emerging need to develop a more
advanced semi-automated method with minimal manual manip-
ulation and no direct modification of the nodule segmentation
boundaries.
The optimization of methods for tumor growth quantification
requires not only time-efficient measurement tools but also their
validation using extensive data sets from growing tumors.
However, these data are not readily available for human patients
because of the large number of repeated CT scans required and
concerns over the associated X-ray dosage. Furthermore, human
patients are subjected to clinical interventions that include surgical
resection or therapies that impair growth. As a result, much of the
research on evaluating the accuracy of measurement methods has
relied on the use of repeat ‘‘coffee break’’ scans, in which patients
are scanned twice over a short period of time [10,11,12,13], or the
use of repeat scans obtained during image-guided biopsy of
pulmonary nodules [14]. These studies have reported measure-
ment variability across repeat scans to be around 25%. It is
unclear whether these data can be accurately extrapolated to
define tumor growth properties.
One common approach to quantify tumor growth is to combine
an empirical tumor volume measurement with a mathematical
model for tumor growth rate. The two most commonly used
growth models are the exponential growth model, in which the
growth rate is proportional to the current value and continues
indefinitely, and the Gompertzian growth model, which resembles
the exponential growth model initially but reduces the growth rate
as time progresses [15,16,17]. However, due to the reasons noted
above, the in vivo growth of human lung cancers has not been
extensively studied. In order to investigate the in vivo lung tumor
growth rate, and to circumvent the limitations of human CT scans
and current manual and semi-automated tumor volume measure-
ment tools, we developed an advanced semi-automated method
for the accurate determination of tumor volume for murine lung
tumors imaged by micro-CT scanning. We hypothesized that the
new semi-automated algorithm would efficiently and accurately
measure lung tumor volume and produce measurement values
that closely correlate with those from careful manual segmenta-
tion. In addition, because we examined early lung tumor growth
when nutrients and space are not expected to be constraining for
tumor growth, we hypothesized that an exponential growth
pattern would be observed.
Micro-CT has previously been used to study lung disease in
mouse models, including chronic inflammation, emphysema, and
cancer [18,19,20,21,22,23]. In this study, we utilized a mouse lung
tumor model based on overexpression of the small subunit of the
enzyme ribonucleotide reductase (RNR). RNR catalyzes the rate-
limiting step in deoxyribonucleotide biosynthesis and plays an
essential role in the maintenance of genome integrity. RNR-
overexpressing mice develop lung adenomas and adenocarcino-
mas at approximately one year of age. These neoplasms
histopathologically resemble human papillary adenocarcinomas,
the most common form of human non-small cell lung cancer [24].
RNR-induced lung tumors frequently contain K-ras mutations,
which also occur in approximately 30% of human lung
adenocarcinomas [25,26]. Unlikely currently used chemical-
induced and activated K-ras-induced mouse lung tumor models
[5,6,8,27], RNR-induced lung tumors arise stochastically via a
mutagenic mechanism caused by genome instability, providing a
unique experimental system to investigate lung tumor growth rate
in vivo.
In this study, initial imaging and volume measurements of
mouse lung tumors were performed to develop and refine an
advanced semi-automated algorithm adapted from tools for the
measurement of pulmonary nodules in human chest CT scans
[28]. This new semi-automated method had minimal requirement
for manual manipulation and did not require any direct
modification of the segmentation boundaries. The algorithm was
first validated by comparing its output with post mortem physical
measurements and manual image analyses. Lung tumor-bearing
mice were then sequentially imaged by micro-CT for tumor
volume measurement and growth rate determination. Tumor
volumes measured by the advanced semi-automated method in
sequential scans were compared with careful manual measure-
ments, and close correlation between methods was observed,
indicating the accuracy of the semi-automated algorithm. In
addition, curve fitting of tumor volumes over time suggested
exponential growth patterns for the analyzed lung neoplasms.
Together, the results described here establish efficient and
accurate tools for tumor volume measurement and provide
insights into in vivo cancer growth properties that will be useful
for future studies of animal models of lung cancer, including pre-
clinical evaluation of candidate therapies.
Materials and Methods
Ethics statement
Mice used in this study were handled in strict accordance with
federal and institutional guidelines. All procedures were approved
by the Cornell University Institutional Animal Care and Use
Committee (protocol number: 2008-0175). Every effort was made
to minimize pain and distress to the animals during the studies. All
mice were euthanized by carbon dioxide asphyxiation in
accordance with American Veterinary Medical Association
guidelines.
Animals, necropsy and histology analyses
Rrm2 and p53R2 transgenic mice (Rrm2Tg and p53R2Tg) were
described previously [24]. All mice were maintained under
identical housing conditions. After the final micro-CT scan, mice
were euthanized by asphyxiation using carbon dioxide and
necropsied. Lungs were photographed using a Canon digital
camera, inflated and fixed with 10% neutral-buffered formalin,
embedded in paraffin, sectioned, and stained with hematoxylin
and eosin (H&E). H&E-stained sections were scanned using an
Aperio ScanScope and physical measurements of lung neoplasms
were made using Aperio ImageScope software. Lung neoplasms
were classified based on guidelines endorsed by the Mouse Models
of Human Cancers Consortium [29].
Micro-CT imaging
Post-mortem imaging. Preliminary scans of mice following
euthanasia were used for initial development and verification of
the algorithm. All scans were acquired using a GE eXplore CT
120 micro-CT scanner, which has been evaluated previously [30].
Three-tumor bearing mice were scanned immediately after they
were euthanized by carbon dioxide asphyxiation.
Mouse Lung Tumor Growth Pattern Analysis
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Live imaging. For live imaging, mice were first put in the
induction chamber and anesthetized with a continuous flow of 4%
isoflurane/oxygen mixture. When the animals stopped moving
and their breathing slowed, they were moved to a Styrofoam
platform in the cradle of the micro-CT scanner with their ventral
side down. Mice were kept under anesthesia using a nose cone
with a continuous flow of 1-3% isoflurane/oxygen mixture that
was maintained during the duration of the micro-CT scan [31].
Respiratory gating of the mice was achieved using a BioVet
physiological monitoring and triggering system (m2m Imaging
Corporation), with a respiratory sensor positioned under the
abdomen of the mouse. A small external force was applied by
taping a piece of paper towel to the back of the mouse in order to
facilitate activation of the pressure sensor used for respiratory
gating. The trigger was set up at the quiescent/refractory period
after each breath in order to minimize motion artifacts.
All scans of the thoracic region were acquired using a GE
eXplore CT 120 micro-CT scanner with a current of 50 mA,
voltage of 100 kVp, exposure time of 20 ms, and acquisition
resolution of 50 mm. Each scan consisted of 720 projections in a
single full rotation of the gantry. Two frames were acquired at
each position of the gantry and averaged prior to being transferred
to the workstation for reconstruction (Table S1). Micro-CT images
were reconstructed at 50650650 mm3 voxel dimensions. The final
image volume varied according to the selected region of interest
but typically ranged from 20620625 mm3 to 40627.5650 mm3.
Half of the total live scans included calibration phantoms with
materials of known densities simulating air, water, and bone. The
densities of the voxels within the phantom were sampled and the
mean and standard deviation of the distribution were computed.
Scans were converted from the manufacturer’s proprietary format
to DICOM and then imported into research software. Scan data
are available for downloading at: http://www.via.cornell.edu/
microdb.html.
The four lung tumor-bearing mice in the study were scanned a
minimum of three times each, with at least three weeks between
scans. The resulting images were examined to identify potential
nodules. For each mouse, at least one tumor was visible in every
scan over the course of the study and was tracked sequentially for
growth rate analysis. Only tumors that were visible on three or
more sequential scans were considered for inclusion in the
longitudinal study to allow for fitting of a growth curve. The
volume of each nodule was computed manually and by the semi-
automated algorithm described in the following sections at each
time point and recorded for growth analysis. Two observers
independently verified the segmentation of the tumors by the
algorithm to make sure the measurements from the semi-
automated algorithm were reliable. Mice were euthanized
following the last live scan, and necropsy and histological analyses
were performed for further characterization of the tumors
identified in micro-CT scans.
Semi-automated volumetric analysis
Algorithm overview. The volume of the murine lung tumors
was computed from the segmentation result produced by a semi-
automated algorithm. The algorithm was adapted from previous
work on semi-automated segmentation of lung tumors in whole
lung CT scans of humans [28]. An overview of the algorithm,
which consists of several steps, is presented in Figure 1. The user
initiates the algorithm by drawing a line across the nodule
indicating the nodule’s extent. The algorithm uses the provided
information to extract a region of interest to analyze. After pre-
processing the image, an adaptive threshold is applied, followed by
filtering to remove attached pulmonary vessels. The lung regions
and their volumes are computed to aid in determining if the
nodule is juxtapleural; if so, an additional step is performed to
separate the nodule from the chest wall. The final result is a binary
image containing only those voxels belonging to the nodule.
Algorithm modifications to enable micro-CT data
analysis. The algorithm used to analyze murine micro-CT
scans was adapted from tools for the measurement of pulmonary
nodules in human chest CT scans [28]. To adapt the algorithm to
analyze murine micro-CT scans, several changes were required.
First, in micro-CT scans, the size of the extracted region of interest
of the scan was clipped to a 56565 mm3 cubic region of interest
(ROI) around the location of the tumor that was manually
provided to the algorithm.
Second, the method for determining the threshold used to
segment the soft tissue from the lung parenchyma was modified to
account for the variation in calibration in the micro-CT scans.
After the micro-CT scan is clipped, a threshold is applied to the
ROI to separate the soft tissue from the lung parenchyma. While
the use of an adaptive threshold does not provide much benefit for
segmenting nodules from human CT scans compared to a fixed
threshold [32], the murine micro-CT scans exhibited significant
variation in the density of the lung parenchyma from one scan to
another. To compensate for this variation, an adaptive threshold
was selected for each scan. A histogram of the ROI, prior to
resampling, was generated. A threshold was established based on
the assumption that the histogram would be bi-modal, with one
peak corresponding to the lung parenchyma and another to the
soft tissue. The threshold was automatically selected to be the
midpoint of the two peaks, as shown by the plot in Figure 2. After
the adaptive threshold was determined, the threshold was applied
to the resampled ROI image to generate a binary image, with all
soft tissue structures labeled.
The remaining steps of the segmentation algorithm were the
same as the one used for human chest CT scans [28]. After the
Figure 1. Flowchart showing the major steps of the semi-automated segmentation algorithm.
doi:10.1371/journal.pone.0083806.g001
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completion of the algorithm, the completed segmentations were
manually reviewed. If the segmentation is not acceptable, several
parameters can be adjusted from the automatically determined
values: the size of the processing filter used to remove vessels; the
size of the region of interest, if there is an excessive or insufficient
amount of the chest wall; and whether or not the tumor is
juxtapleural. These parameters are only adjusted relative to the
algorithm-derived values and typically only require a small
adjustment. The size of the vessel processing filter controls the
extent of vessel-like structures that are included in the segmenta-
tion of the tumor. The size of the ROI is set to be large enough to
totally encompass most nodules and provide a sufficient portion of
the chest wall to allow for the correct function of the surface fitting
algorithm, but not any larger than necessary to limit the
computation time and avoid including other non-tumor structures.
In some cases, the ROI had to be increased by 1.0 mm for nodules
that were larger than the ROI.
Manual tumor measurements
The tumor volumes measured by the semi-automated algorithm
were compared to those generated by manual measurement
procedures. The approximate volume of all tumors in the study
was measured manually using the following method. In every fifth
slice through the tumor, an observer performed a bi-dimensional
measurement consisting of a line drawn along the greatest extent
of the tumor and a perpendicular line that spanned the greatest
extent of the tumor in the other dimension. The average of these
two measurements was used to establish the diameter of a cylinder
with a height of 5 slices (0.25 mm). In this manner, manual
measurements were made across the full thickness of the tumor,
and the resulting volumes were summed to obtain an approxima-
tion of the nodule volume. In order to validate this manual
approximation of nodule volumes, we also measured the volumes
of a subset of tumors by complete manual 3D segmentation in
which the tumor boundaries were outlined manually in all slices.
Growth analysis
In this study, each mouse was scanned several times. Tumors
were identified and their volumes were measured for each scan.
Tumor growth can be determined from the tumor volume and
time interval between scans. Exponential growth can be modeled
by the following equation:
V2~V1e
r(t2{t1)
where V1 is the volume at time t1, V2 is the volume at time t2, and
r is the growth rate.
A nonlinear regression curve fitting was performed using
GraphPad Prism. The exponential growth equation analysis gave
the tumor growth rate r for all the tumors studied.
The tumor volume doubling time (VDT, defined as ln2/r), as
well as the growth index (GI), was calculated for tumors observed
in the scans. GI, the percent tumor growth per month, was defined
as follows:
GI~100 (V2=V1)
(30:44=(t2{t1)){1
h i
The value 30.44 is the average number of days per months.
Rearranging this equation gives a GI value that can be calculated
using the slope r of the best-fit exponential curve:
GI~100 e30:44r{1
  ð3Þ
In contrast to VDT where a lower value indicates faster growth,
a higher GI represents faster growth. VDT can be converted to GI
by the following equation:
GI~100 230:44=VDT{1
h i
The manual and semi-automated methods for calculating tumor
volumes were compared by plotting ln (volume) versus time and
obtaining the best-fit lines. The slopes of these lines were
compared by Student’s t test. The R-squared values were used
to evaluate the goodness of fit with a 95% confidence interval.
Results
In this study, we used micro-CT to monitor the progression of
murine lung tumors in vivo. Prior to imaging live mice, post-
mortem imaging of three lung tumor-bearing mice was performed
in order to optimize and validate the measurement algorithm.
Figure 3A shows a micro-CT image of the lungs from a euthanized
mouse scanned with 360 projections, reconstructed at
50650650 mm3 resolution. The neoplasm apparent in the
micro-CT scan was also identified on the histological slide of the
corresponding lung lobe (Figure 3B). The neoplasm is an
adenoma, with a clear border between the solid tumor mass and
surrounding lung parenchyma. Higher magnification images of
the histological section clearly showed that the tumor region is
much denser than the surrounding lung parenchyma, hence the
different densities of these tissues observed in micro-CT. We then
Figure 2. Histogram showing voxel densities of the lung
parenchyma and soft tissue in a region of interest. Voxel
densities of a region of lung from an RNR transgenic mouse including a
nodule were sampled and used to create the histogram. Bins were set
at 10 HU. The peak on the left represents the lung parenchyma and the
peak on the right represents the soft tissue. The line in the middle
indicates the calculated adaptive threshold by the semi-automated
algorithm. The data shown were from a scan taken at 50 mm with 720
projections.
doi:10.1371/journal.pone.0083806.g002
Mouse Lung Tumor Growth Pattern Analysis
PLOS ONE | www.plosone.org 4 December 2013 | Volume 8 | Issue 12 | e83806
compared tumor size as determined by physical, image-based
manual, and semi-automated computational approaches, using
maximum tumor diameter as the readout that could be most
readily assessed using all three measurement methods (Table S2).
The diameter of this tumor was determined to be 1.94 mm by
physical measurement of a histological section. Manual measure-
ment of micro-CT scans was used to determine the volume of the
same tumor, and the diameter was calculated to be 2.06 mm.
Next, the semi-automated algorithm was used to measure the size
of the same tumor. The ROI including the tumor is illustrated in
Figure 3C, with every fourth image from the tumor segmentation
shown. A 3D visualization of this segmented tumor was then
generated with axial, sagittal and dorsal views shown in Figure 3D.
Consistent with the histological and manual measurements of the
tumor, the diameter computed by the algorithm was 2.03 mm.
Physical, manual and computed measurements for three addi-
tional tumors from two tumor-bearing mice were compared and
also found to be highly similar, with the difference in tumor
diameter between the manual and semi-automated measurement
methods ranging from 1.47% to 4.49% (Table S2). Together,
these results provided an initial validation of our computational
methods for semi-automated measurement of mouse lung tumors
from micro-CT images.
Live micro-CT scanning was then performed on four lung
tumor-bearing mice. All live scans were acquired using the
following parameters: 100 kVp, 50 mA, 20 ms, 720 projections, 2
frame averaging and acquisition and reconstruction at 50650650
mm3 resolution, with the exception of two scans (Table S1). 12
tumors in total were detected in the four mice, and ten tumors
were successfully segmented by the semi-automated algorithm
(Table S3). Each mouse was euthanized following the final scan,
and necropsy and histological analyses were performed to confirm
tumors that were detected by micro-CT scans. Of the ten
successfully segmented tumors, six were detectable at three or
more time points, permitting their use for growth analysis. To
validate the accuracy of the algorithm in live studies, we first
compared the volumes of the four nodules not used for growth
analysis as measured by the algorithm with the volumes measured
for the same tumors manually (Table S4). Consistent with the
findings from post-mortem scans indicating that the semi-
automated algorithm was accurate, no significant difference was
observed between volume measurements made by the algorithm
or manually for the tumors from these live imaging studies (Table
S4, paired Student’s t-test, P = 0.57).
Next, the volumes of the six nodules used in growth analysis
were computed at each time point and recorded for growth
pattern analysis (Figure 4A to C, Figure S1, and Table S5). The
fold change in tumor volume over time for each nodule is
illustrated in Figure 4D and 4E. The initial volume for the tumors
in Figure 4D was approximately 0.050 mm3 while the initial
volume for the tumors in Figure 4E ranged from 0.190 mm3 to
0.898 mm3 (mean 0.3665 mm3, median 0.257 mm3). The growth
index (GI) and volume doubling time (VDT) for each tumor is
provided in Table 1. The growth curves of the tumors in Figure 4
were suggestive of an exponential growth pattern, with deviation
from a perfect exponential model. Variation from the micro-CT
scanner due to alterations in calibration from scan to scan could
contribute to such a deviation. This possibility was assessed using
data for phantoms of known density that were scanned together
with the mice. Histograms for the distribution of densities for air,
water, and bone phantoms were plotted for two scans of the same
mouse (Figure 5A, B), with mean and standard deviation values
reported in Table S6. While the mean density of the air phantom
between the two scans only varied by 4.2 Hounsfield Units (HU),
the means for the water and bone phantoms differed by 25.7 HU
and 20.6 HU, respectively. The noise of the scans, which was
quantified by the standard deviation of the distribution of pixel
values in the phantoms, also differed from scan to scan. The
greatest difference in standard deviation between the two scans
occurred with the air phantom, where there was a 30.9 HU
difference. The difference in standard deviation between the two
scans decreased as the mean density increased, with the difference
for water and bone being 24.7 HU and 3.4 HU respectively. In
addition to phantoms, we also measured the voxel densities of the
lung parenchyma and soft tissue from different scans to see
whether they were consistent. Figure 5 shows the distribution of
voxel densities for the lung parenchyma and soft tissue from two
different scans of the same mouse (mouse 4; Figure 5C and 5D).
The value that best separated the lung parenchyma from soft tissue
varied by 35 HU from one scan to the other. These data identify
scan-to-scan variability in calibration and tissue density measures.
Next, we investigated whether differences in mouse positioning
or disease progression could contribute to measurement variation
between scans, possibly by affecting nodule morphology. This
possibility was assessed by comparing total lung volume across all
scans for each mouse. The difference between the minimum and
maximum lung volume measurement was 43.7% (mean volume
524.0 mm3, standard deviation 82.3 mm3) for mouse 2, 60.8%
(mean volume 484.3 mm3, standard deviation 79.9 mm3) for
mouse 3, and 28.2% (mean volume 576.6 mm3, standard
deviation 57.7 mm3) for mouse 4. These findings indicate that
there were substantial changes in total lung volume for individual
mice between imaging sessions.
In addition, inaccuracy of tumor volumes measured by the
semi-automated algorithm could also contribute to deviations in
the exponential model. To test whether the algorithm accurately
measured tumor volume changes over time, we compared the
change in tumor volume over time as measured manually and as
computed by the algorithm, for each of the six nodules used in the
tumor growth analyses. Two different manual measurements were
used, based on either complete manual segmentation of each
tumor or a simplified approximation method for manual
measurement as described in the Materials and Methods section.
No significant differences were observed for values from any of
these three measurement methods (Table S5, one-way ANOVA,
P= 0.06). In addition, because the tumors showed exponential
growth, the tumor volumes from both measurements were
converted to a log scale and the resulting best-fit lines were
compared (Figure 6 and Figure S2). Statistical comparison of the
slopes of the best-fit lines revealed no significant differences
between the values from semi-automated and manual measure-
ments (see legend of Figure S2 for P-values), confirming that the
semi-automated algorithm accurately measures tumor volumes in
vivo.
Discussion
The development of micro-CT has provided an opportunity to
monitor disease progression and therapeutic responses over time in
mouse models of human diseases. To further explore this
opportunity and improve the measurement tools, we developed
a semi-automated method to measure tumor volume in micro-CT
scans from a mouse lung cancer model. Several studies have
examined in vivo tumor growth in mouse models imaged with
micro-CT using semi-automated measurement methods. These
typically required manual editing of the segmentation boundary
[7,8] or a large number of manually specified seed points [9]. In
contrast to existing semi-automated methods, the semi-automated
Mouse Lung Tumor Growth Pattern Analysis
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method in this study only requires a single stroke across the nodule
on the central slice, and optionally allows for manual adjustment
of three parameters: the size of the processing filter used to remove
vessels; the size of the region of interest, if there is an excessive or
insufficient amount of the chest wall; and whether or not the
tumor is juxtapleural. This advanced semi-automated method
required minimal manual intervention, and manual boundary
modification is not allowed, making it more efficient and less labor
intensive. Another recent report described an automated method
for lung nodule segmentation from micro-CT images that, like the
approach reported here, also enables accurate tumor volume
measurement in longitudinal studies [33].
Micro-CT scans present an additional challenge for segmenta-
tion algorithms compared to clinical human CT scans. Although
Figure 3. Micro-CT and histological analyses of an RNR transgenic mouse lung tumor. (A) Micro-CT image of lung (sagittal view) from an
RNR transgenic mouse with a tumor (red circle generated manually). Image was derived from a scan taken at 50 mm with 220 projections. The scale
bar represents 5.0 mm. (B) H&E stained lung tissue from the same mouse. The scale bar represents 1000 mm. Normal and tumor tissues are also
shown at a higher magnification. The scale bar represents 40 mm. The tumor diameter was measured to be 1.94 mm by histological analysis. (C) Black
and white panels: Several slices (every 4th slice shown) through a small region of interest including the tumor in (A). The scale bar represents 2.5 mm.
Color panels: The same tumor separated by the semi-automated segmentation algorithm from other soft tissue structures such as blood vessels and
the chest wall. The result is shown with the tumor in red and other soft tissue structures in green. The color bar range is 2725 to 625 HU. (D) A 3D
visualization of the segmented tumor in (C) showing axial, sagittal, and dorsal views. The volume equivalent diameter of the tumor was calculated by
the semi-automated algorithm to be 2.03 mm.
doi:10.1371/journal.pone.0083806.g003
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we used a set of scan parameters that provided the least amount of
noise given our radiation dosage limitations, the noise level in
these micro-CT scans was still higher than what is typically
obtained using low-dose whole lung human CT scans for which
the algorithm was originally designed. This is due in part to the
scale at which micro-CT operates – the image noise is inversely
Figure 4. Sequential micro-CT scans over time to measure lung tumor growth rate in four RNR transgenic mice. (A) Images of
sequential micro-CT scans of an RNR transgenic mouse (mouse#3 tumor A; red circle generated manually). Images were acquired at 50 mm with 720
projections. The scale bars represent 5.0 mm. The color bar range is 2700 to 400 HU. (B) Gross image of the lungs at necropsy showing the tumor
(black arrow) after the last scan. (C) H&E stained section from lungs shown in (B). The scale bar represents 1000 mm. Normal and tumor tissues are also
shown at a higher magnification. The scale bar represents 40 mm. (D, E) Growth curves of lung tumors from four RNR transgenic mice. Fold change in
lung tumor volume was plotted against time from the first micro-CT scan. A best-fit exponential curve was used to model the growth of each tumor.
Note that Mouse 1 showed very slow growth, which could be due to inconsistency in tumor volume measurement because different scan parameters
were used for mouse 1 time point 3 and this was the first live mouse scanned, when the micro-CT instrument was not calibrated for each scan.
doi:10.1371/journal.pone.0083806.g004
Figure 5. Phantoms and tissues show variation in densities across different scans. (A) Distribution of densities of three phantoms, air,
water, and bone (left to right peaks), with mean densities 2927.6 HU, 92.2 HU, and 2612.6 HU, respectively, in one scan. (B) Distribution of densities
of the same phantoms as in (A) in a repeated scan six weeks later with mean densities 2931.8 HU, 66.5 HU, and 2592.0 HU, respectively. (C)
Distribution of densities in the lung parenchyma (white) and soft tissue (gray) from one mouse in one scan with an adaptive threshold at 2155 HU.
(D) Distribution of densities of the same tissues as in (C) of the same mouse in a repeated scan six weeks later with an adaptive threshold at2190 HU.
All scans were acquired at 50 mm with 720 projections. Variations in the density distribution of the phantoms and tissues were observed in repeated
scans.
doi:10.1371/journal.pone.0083806.g005
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proportional to the spacing between the voxels, if X-ray exposure
is held constant [34]. The micro-CT scans in this study were
acquired with a voxel size of 0.0560.0560.05 mm3 compared to
typical human CT scans of 0.660.661.0 mm3. Figure 7 shows a
single snapshot of a typical low-dose human CT scan obtained
from the Public Lung Database to Address Drug Response as well
as a micro-CT scan obtained in this study. Visually, the micro-CT
scan has a noisier appearance, as evidenced by the texture pattern
of the lung parenchyma compared to that of the human CT scan
(Figure 7C and 7D). The increase in noise is reflected in the
histogram shown in Figure 7A, in which the micro-CT scan has a
much wider distribution of densities than the human CT scan
shown in Figure 7B. The mean and standard deviation of the
distributions are given in Table S7. Nevertheless, the semi-
automated algorithm developed in this study is able to cope with
the noise level found in micro-CT scans, as illustrated by the
successful segmentation of tumors in Figure 3D.
The semi-automated algorithm used in this paper successfully
segmented 10 out of 12 tumors detected in live scans of four mice.
One limitation the semi-automated algorithm has is that it cannot
properly segment tumors that have complicated morphology. One
assumption made during the development of the algorithm was
that the tumor would only touch the outer chest wall. As a result,
two tumors that were located in the lower lung near the
diaphragm and touched both the chest wall and the diaphragm
could not be successfully segmented (Figure S3).
The growth curves of the tumors followed an exponential
pattern, which is consistent with modeling of tumor growth
patterns for human lung cancers [35,36]. It is also consistent with a
recent CT study showing exponential growth in early stage
pancreatic cancers [37]. Therefore, our in vivo murine lung tumor
growth study is consistent with the exponential growth model of
early lung tumors, for which nutrients, gases and physical space
are not limiting, and supports its use in tumor measurement
algorithms to monitor disease progression and therapeutic
responses. At larger tumor sizes, cell division no longer proceeds
in an unconstrained fashion and non-exponential growth patterns
have been reported [16,17,38]. It also should be noted that the
growth curves obtained in this study showed deviations from an
ideal exponential model, although it remains unknown whether
this accurately reflects the actual growth behavior of the tumors.
We found that alterations in scanner calibration and changes in
mouse lung volume are factors that could contribute to
measurement variability.
One characteristic of CT is that the scale is calibrated. Air has a
density of 21000 HU and water has a density of 0 HU. Thus,
materials of the same density should have a consistent density in
CT scans, both across time and instruments. This allows for the
use of a fixed threshold to separate different tissue types, in this
case for the lung parenchyma and soft tissue. However, in this
study, we observed inconsistencies in calibration and noise
characteristics from scan to scan that could contribute to
measurement variation and deviation from a perfect exponential
growth curve. The semi-automated algorithm in this study used an
adaptive threshold estimated from the local ROI instead of a fixed
threshold to address this variation in calibration. These findings
additionally suggest that the micro-CT scanner should be
Table 1. Tumor volume doubling time and growth index of tumors detected in RNR transgenic mice by micro-CT.
Mouse (Tumor)
Age at first scan
(month)
Initial tumor volume
(mm3)
Growth
curve slope
Tumor volume doubling
time ( = ln2/slope) (days)
Growth index [ =100(e30.44*slope-1)]
(% increase per month)
1 11 0.685 0.0057 121.6 18.95
2 12 0.898 0.0182 38.08 74
3(A) 12 0.324 0.0096 72.2 33.94
(B) 0.052 0.0297 23.34 147.0
4(A) 11 0.190 0.0134 51.73 50.36
(B) 0.050 0.0195 35.55 81.04
NOTE: mice were first scanned at the indicated age and then subjected to a series of sequential scans to monitor tumor growth. The slope of the growth curve was
converted to tumor doubling time and growth index to indicate the rate of tumor growth.
doi:10.1371/journal.pone.0083806.t001
Figure 6. Comparison of lung tumor growth measured manually by an observer and by the semi-automated algorithm. Best linear fit
growth curves were plotted for tumors from mouse 2 (left) and mouse 4 tumor A (right) based on measurements by a manual approximation method
and by the semi-automated algorithm. The slopes of the best-fit lines for the manual and semi-automated measurements were compared by
Student’s t-test, and no significant differences were observed between the two slopes (P = 0.62 for mouse 2 and P= 0.57 for mouse 4 tumor A).
doi:10.1371/journal.pone.0083806.g006
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calibrated prior to each scan using density phantoms that span the
entire range of densities to be observed in the scan.
We also observed changes in lung volume between live scans for
individual mice. The lung volume of the same mouse varied up to
60% from one scan to another as measured by the algorithm. It is
currently not possible to determine how changes in total lung
volume might affect tumor volume measurements; we cannot rule
out the possibility that differences in lung volume could affect
tumor volume measurements because of the associated variation in
distending forces from the surrounding parenchyma. Slight
differences in mouse positioning between scans could affect the
shape and inflation of the lung, which in turn could contribute to
observed differences in lung volume. In addition, as lung disease
progressed, the increased tumor burden resulted in reduced
respiratory capacity, which might be another factor contributing
to changes in observed lung volume. Furthermore, in order for the
mouse to activate the pressure sensor used for respiratory gating
during live scans, a small external force was applied on the back of
the mouse, which could lead to slight compression of the lungs. An
alternative method for respiratory gating is to use a ventilator to
control the respiratory cycle of the mouse [39]. This would
eliminate the need for a pressure sensor and provide better control
of the degree and rate of inspiration.
Manual tumor volume measurements were made to provide
validation of the semi-automated method. Although uni- and bi-
dimensional measurements on a single slice are typically
performed in clinical practice [40], such as the method specified
by Response Evaluation Criteria In Solid Tumors (RECIST) [41],
Figure 7. Comparison of soft tissue and lung parenchyma densities in a micro-CT scan and a human whole lung CT scan. Distribution
of densities in the lung parenchyma (white) and soft tissue (gray) in (A) a mouse micro-CT scan with adaptive threshold of2190 HU and (B) a human
whole lung CT scan with no need for adaptive threshold. The mouse micro-CT scan was obtained at 50 mm with 720 projections. The human whole
lung CT scan was from the Weill Cornell Medical College Lung CT database. It was obtained using a GE LightSpeed Ultra scanner at 120 kVp and
80 mA, with 0.760.761.25 mm3 resolution. The peaks in (A) were not as sharp as those in (B), indicating that the mouse micro-CT scans were noisier
than human CT scans. Magnified regions of the lung from (C) a micro-CT scan (yellow circle indicates tumor) and (D) a whole-lung CT scan (red arrow
points to tumor) are shown to visualize the difference in scan quality. No scaling was done to the images and each image was windowed for viewing.
The scale bars represent 5.0 mm (mouse micro-CT image) or 70.3 mm (human CT image). The color bar range is 2750 to 849 HU (mouse micro-CT
image) or 21400 to 100 HU (human CT image).
doi:10.1371/journal.pone.0083806.g007
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we performed bi-dimensional measurements on every 5th slice
throughout the tumor to improve the accuracy of the manual
measurements and used a cylindrical approximation to estimate
the tumor volume without requiring a full manual segmentation of
the tumor. Since this method is not typically used, we validated
this manual measurement against a full manual segmentation of a
subset of the tumors. As shown in Figure S2, there was good
agreement between complete manual segmentation and the bi-
dimensional manual approximation.
The neoplasms analyzed in this study were all adenomas. The
GI values for these tumors ranged from 18.94 to 146.9% per
month (mean 67.55%, median 62.18%), which is much greater
than the GI of 5.4% per month reported for human lung tumors
[42], indicating that the murine tumors grow faster. This likely is
due at least in part to the fact that, relative to larger human
tumors, the tumors in mice were detected at an early stage when
they experience preferential growth conditions, including greater
nutrient access, oxygenation and less spatial constraint. Similarly,
tumors with smaller initial volumes in this study tended to grow
faster, although the limited sample number in our study of lung
neoplasms precludes definitive conclusions on this point. Haeno et
al. [37] previously reported that primary pancreatic tumors that
were larger at diagnosis grew slower. Tumor VDT for the tumors
analyzed in this study ranged from 23.34 to 121.6 days (Table 1),
with an average of 57.08 days. These values are similar to
published VDT values for mouse lung adenocarcinoma. Oliver et
al. [43] reported an average mouse lung tumor VDT of 35 days
(with high variation). Haines et al. [5] and Fushiki et al. [6] showed
an average VDT for murine lung tumors of around 42 days. These
published studies all used the K-rasLSL-G12D mouse model, in
which expression of the activated K-ras oncogene is induced
following Adeno-Cre viral infection [44]. In comparison, lung
tumors arise in the mouse model used in the present study through
a stochastic process that also is associated with mutations in the K-
ras oncogene [24]; differences between the mouse models used
may contribute to the modest variation in average tumor VDT
observed. A recent study in human lung cancer patients revealed
an average tumor VDT of 136 days for 111 lung cancer cases [45].
110 of the 111 cases had lung tumors diagnosed at screening
rather than by symptoms, suggesting that the average VDT of 136
days reflects tumor growth at an early stage and provides a basis
for comparison with the average VDT of 57.08 days in our mouse
model. Aside from cancer cell-intrinsic factors, previous research
has identified the tumor microenvironment provided by the host,
including capillary density and metabolic activity in surrounding
tissues, as a key, species-specific determinant of tumor growth rate,
with mouse tissue typically supporting more rapid tumor
proliferation [38,46].
The semi-automated pulmonary nodule segmentation algo-
rithm for measuring murine tumors imaged by micro-CT reported
here was capable of accurate measurements of tumor volumes and
was used to monitor disease progression over time. Tumor volume
measurements from micro-CT have the potential to be used as an
imaging biomarker in preclinical studies. With future improve-
ments to handle nodules with more difficult morphology, this
automated algorithm holds promise for use in monitoring disease
progression following treatment with candidate drugs and
evaluation of therapeutic responses.
Supporting Information
Figure S1 Analysis of lung tumor growth in RNR
transgenic mice by sequential micro-CT scanning.
Micro-CT imaging was performed on RNR transgenic mice,
and representative micro-CT images from each imaging session are
shown for (A) mouse #1; (B) mouse #2; (C) mouse #3 tumor B; (D)
mouse#4 tumor A; (E) mouse#4 tumor B. All images were acquired
at 50 mm with 720 projections. The time point of the scan and the
calculated tumor volume are indicated. Manually generated red
outlines highlight the tumor analyzed in each image. Also shown are
H&E stained sections that were generated for each sample following
the final imaging session. Scale bars represent 5.0 mm (CT images) or
1000 mm (H&E image). The color bar range is -800 to 500 HU.
(TIF)
Figure S2 Comparison of lung tumor volume values
determined manually by an observer and by the semi-
automated algorithm. Four tumor-bearing mice were subject-
ed to sequential micro-CT imaging, and tumor volume measure-
ments of six tumors were determined manually by an observer and
by the semi-automated algorithm. (A) mouse #1, (B) mouse #2,
(C) mouse #3 tumor A, (D) mouse #3 tumor B, (E) mouse #4
tumor A, and (F) mouse #4 tumor B. The volumes of all six
tumors were measured over time by a manual approximation
method as described in Materials and Methods. The slopes of the
plotted lines for the manual approximation and semi-automated
measurements were compared by Student’s t-test, and no
significant differences between the two slopes were observed
(mouse 1: P= 0.40; mouse 2: P= 0.62; mouse 3 tumor A: P= 0.99;
mouse 3 tumor B: P= 0.69; mouse 4 tumor A: P= 0.57; mouse 4
tumor B: P= 0.55). In addition, the volumes of three tumors over
time were further measured by manual complete 3D segmentation
(mouse 2, mouse 3 tumor A and mouse 4 tumor B). The slopes of
the plotted lines for the manual complete segmentation, manual
approximation and semi-automated measurements were com-
pared by one-way ANOVA and no significant differences among
the three slopes were observed (mouse 2: P = 0.30; mouse 3 tumor
A: P= 0.63; mouse 4 tumor B: P= 0.80).
(TIF)
Figure S3 Representative micro-CT images showing a
nodule that is attached to both the chest wall and
diaphragm. Micro-CT images of a nodule from mouse #3 that
abuts the chest wall and diaphragm are shown. This nodule could
not be successfully segmented by the semi-automated algorithm
because it violates the assumption of the algorithm that the nodule
can only have one major attachment. These images were
windowed to enhance the contrast for viewing and representative
segmentations that are seven slices apart are shown. This scan was
acquired at 50 mm with 720 projections. The scale bars represent
5.0 mm. The color bar range is 2625 to 1225 HU.
(TIF)
Table S1 Scanner acquisition parameters used for live
scans.
(DOCX)
Table S2 Comparison of tumor sizes determined by
physical measurement from histological slides or by
analysis of post-mortem micro-CT scans.
(DOCX)
Table S3 Summary of tumors detected, segmented and
used from growth analysis for each mouse in live micro-
CT scans.
(DOCX)
Table S4 Comparison of manual and semi-automated
tumor volume measurements for tumors that were
successfully segmented but not used in growth analysis.
(DOCX)
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Table S5 Comparison of raw tumor volume measure-
ments of tumors used in growth analysis by manual and
semi-automated methods.
(DOCX)
Table S6 Descriptive statistics for the densities of the
histogram plots in Figure 5A.
(DOCX)
Table S7 Descriptive statistics for the densities of the
histogram plots in Figure 7.
(DOCX)
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